Category Archives: Pr Newswire

Uxin to Report Fourth Quarter and Fiscal Year 2024 Financial Results on July 31, 2024

BEIJING, July 25, 2024 /PRNewswire/ — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced that it will release its financial results for the fourth quarter and fiscal year 2024 ended March 31, 2024, before the U.S. market opens on July 31, 2024. Uxin’s management team will host a conference call […]

Altair Announces Winner of the 2023-2024 Altair Global Student Contest

Luca Sutton of the TUfast Eco Team slashed 41% of weight from Shell Eco-marathon vehicle suspension with Altair® Inspire™ TROY, Mich., July 25, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader in computational intelligence, is thrilled to announce Luca Sutton, a member of the TUfast Eco Team, as the grand prize winner of the 2023-2024 Altair […]

DCG’s AI+Publishing Dazzle at the 34th HKTDC Hong Kong Book Fair

HONG KONG, July 25, 2024 /PRNewswire/ — The 34th HKTDC Hong Kong Book Fair recently commenced at the Hong Kong Convention and Exhibition Center, where DCG, a pioneer in AI+Publishing, presented its impressive range of outcomes, drawing the attention of a large audience. During the exhibition, multiple Hong Kong publishers expressed their intent to engage in […]

IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication — Systemic Lupus Erythematosus (SLE)

SHANGHAI, NANJING, China and SAN JOSE, Calif.  , July 25, 2024 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, hereby announces that the investigational new drug (IND) application for IASO-782 Injection, a fully human monoclonal antibody targeting human CD19, has been approved […]

Jushi Holdings Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024

BOCA RATON, Fla., July 24, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the second quarter ended June 30, 2024, after the market closes on Wednesday, August 7, 2024. Management will host […]

HNL Lab Medicine Opens Gilbertsville Location

ALLENTOWN, Pa., July 24, 2024 (GLOBE NEWSWIRE) — HNL Lab Medicine, a leading diagnostics laboratory, announced the opening of a new Patient Service Center. Located at 1107 Grosser Road, Gilbertsville PA, this new facility will offer pediatric lab services in addition to HNL Lab Medicine’s extensive menu of laboratory testing services. With a tentative opening […]

Amedisys Reports Second Quarter 2024 Financial Results

BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to $591.2 million compared to $553.0 million in 2023. Net income attributable to Amedisys, Inc. […]

Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference

FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences: CFO, Peter Kuipers, will participate in a fireside chat presentation […]

TransCode Therapeutics, Inc. Announces Closing of Public Offering

BOSTON, July 24, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously announced public offering of 10,000,000 shares of its common stock at a public offering price of $0.30 per […]